Fig. 1 · Structure
Documents & Downloads
N,N-Dipropyldopamine hydrobromide
Glutamate Release Inhibitor
N,N-Dipropyldopamine hydrobromide is a potent inhibitor of glutamate release. This compound exhibits significant anticancer activity by reducing glutamate secretion, which is associated with cancer-induced bone pain (CIBP). N,N-Dipropyldopamine hydrobromide may serve as a valuable tool in the study of analgesic effects in CIBP models and offers insights into the modulation of glutamate signaling in cancer research.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 65273-66-7 |
| Applications | Glutamate Release Inhibitor |
| Formula | C14H24BrNO2 |
| Molecular Weight | 318.25 |
| SMILES | OC1=CC=C(CCN(CCC)CCC)C=C1O.[H]Br |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.